DIALYSIS · CCN 052802

DaVita Harbor UCLA

Torrance, CA 90502

DialysisProfitDaVita
$10.4M
TOTAL REVENUE
14.6%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$10.4M
Total costs
$8.9M
Operating income (rev − costs)
$1.5M
Operating margin
14.6%
Total charges
$10.8M
Total treatments
30,666
Dialysis stations
30

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.15162—
Fistula Rate
DFC_FISTULA_RATE
66.8188—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.2388—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
2——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
116.2121—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.58——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
14188—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
13.4501—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
24.7218—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.2110—
Standardized ED Visits Ratio
DFC_SEDR
0.8298—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
15.386—